These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 3811540)
21. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. Brunzell JD; Hazzard WR; Porte D; Bierman EL J Clin Invest; 1973 Jul; 52(7):1578-85. PubMed ID: 4352459 [TBL] [Abstract][Full Text] [Related]
22. Classification and etiology of hyperlipoproteinemias. Levy RI Fed Proc; 1971; 30(3):829-34. PubMed ID: 5575295 [No Abstract] [Full Text] [Related]
23. Type IV hyperlipoproteinemia. A critical appraisal. Schonfeld G; Kudzma DJ Arch Intern Med; 1973 Jul; 132(1):55-62. PubMed ID: 4716427 [No Abstract] [Full Text] [Related]
24. [Role of lipolytic enzymes in the physiopathology of plasma lipoprotein metabolism]. Szeszko A; Lutz W Pol Tyg Lek; 1982 Jul; 37(22):657-61. PubMed ID: 6757901 [No Abstract] [Full Text] [Related]
28. Clues to the diagnosis of hyperlipoproteinemia. Scheig R Am Fam Physician; 1972 Nov; 6(5):82-5. PubMed ID: 4343861 [No Abstract] [Full Text] [Related]
29. [Xanthomatosis eruptiva papulosa (hyperlipoproteinemia type V)]. Vigh C; Czinder K; Mátyus L Z Hautkr; 1974 Oct; 49(19):819-28. PubMed ID: 4464725 [No Abstract] [Full Text] [Related]
31. [Significance of the lipidogram (Lees-Hatch technic) associated with the determination of serum lipid fractions for the detection and classification of hyperlipoproteinemias. (Apropos of 100 arteriosclerosis patients)]. Loeper J; Tricot R; Rouffy J Presse Med (1893); 1969 Jan; 77(5):171-2. PubMed ID: 5771795 [No Abstract] [Full Text] [Related]
37. Turbidimetric estimation of chylomicrons and very low density lipoproteins in human sera after precipitation by sodium lauryl sulfate. Burstein M; Scholnick HR Biomedicine; 1973 Jan; 19(1):16-9. PubMed ID: 4351005 [No Abstract] [Full Text] [Related]
38. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients. Baggio G; Manzato E; Gabelli C; Fellin R; Martini S; Enzi GB; Verlato F; Baiocchi MR; Sprecher DL; Kashyap ML J Clin Invest; 1986 Feb; 77(2):520-7. PubMed ID: 3944267 [TBL] [Abstract][Full Text] [Related]
40. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V]. Hutt V; Wechsler JG; Klör HU; Ditschuneit H Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]